Clinical presentation, management, and outcomes in posterior segment open globe injuries
This is a retrospective, non-comparative, interventional case study of patients presenting with scleral and corneoscleral wounds covering a five-year period. It reports the clinical presentation, management, and factors affecting the outcomes of posterior segment open globe injuries (OGI) in 2360...
Surgical correction of lacrimal gland prolapse
This is a systematic review of published literature on the management of lacrimal gland prolapse or ptosis. The authors found 16 publications which contained a description of any surgical correction of a prolapsed lacrimal gland, comprising seven case reports, four...
Ophthalmic presentations and outcomes in Erdheim-Chester disease
This is a comprehensive article describing clinical manifestations and pathogenesis of Erdheim-Chester disease (ECD) followed by a literature review of the available treatments. The authors look to compare historical treatment (HT) with vemurafenib, a BRAF inhibitor. ECD is a non-Langerhans...
Differentiating orbital cellulitis from non-specific orbital inflammation
This is a retrospective study looking at whether common laboratory investigations can help differentiate between orbital cellulitis (OC) and non-specific orbital inflammation (NSOI). NSOI is a diagnosis of exclusion following negative investigations for systemic diseases such as IgG4-related disease, granulomatosis...
Telemedicine for postoperative reviews
This is a detailed study looking at the use of telemedicine in the context of a postoperative review following oculoplastic and orbital surgery. The authors combined a video consultation (telephone if there were technical issues) with a ‘pre-visit tool’ that...
Normative dimensions of the lacrimal gland
This article looks at the normative dimensions of the lacrimal gland in the axial and coronal plane on fat-suppressed T1 weighted contrast-enhanced magnetic resonance imaging (MRI). Previous data on this subject has come from computed tomography (CT). MRI is known...
Evisceration in India: demographic and clinical trends from a large multicentre cohort study
In this multicentre cohort study, the authors investigated a total of 2071 patients who underwent evisceration with primary implant placement over a six-year period at four tertiary eyecare centres in India. Out of 1,345,480 new ophthalmic presentations during the study...
Intravenous ketorolac during DCR
This study compares pain scores postoperatively between patients that received intravenous ketorolac (IVK) pre, intra or immediately postoperatively and a control group that did not receive it. The authors state that the patients were randomised, however it is not described...
Hering’s response in ptosis surgery
his is a prospective study of the Hering’s response in patients undergoing Muller’s muscle-conjunctival resection (MMCR) ptosis surgery, with a particular reference to the accuracy of preoperative phenylephrine testing. Patients with unilateral ptosis were assessed clinically preoperatively, in the immediate...
Pain control during orbital implant surgery
This is a study based on existing evidence that pre-emptive pain control has advantages over traditional post-surgical analgesia. The authors compared pain scores in three groups of randomly assigned and masked patients all undergoing orbital implant surgery under general anaesthesia...
Subperiosteal abscess management in adolescents and adults
This is a retrospective study looking at the clinical and treatment profiles of patients with orbital subperiosteal abscess (SPA) in an adolescent and adult population. SPA is rarer in this age group compared to a paediatric population (less than nine-years-old)...
Therapeutic options for advanced cutaneous basal (BCC) and squamous cell carcinomas (SCC)
This article discusses the use of topical and systemic therapy in the management of advanced periocular tumours. It focuses on those that have gained United States Food and Drug Administration approval; namely imiquimod, vismodegib, sonidegib, pembrolizumab and cemiplimab. Imiquimod is...